After hours of debate, the Food and Drug Administration’s vaccine advisory committee voted Thursday in favor of recommending emergency authorization of Moderna coronavirus vaccine boosters, but only for those most at risk from the virus. Stay Connected Forbes on Facebook: http://fb.com/forbes Forbes Video on Twitter: http://www.twitter.com/forbes Forbes Video on Instagram: http://instagram.com/forbes More From Forbes: http://forbes.com